Skip to content
The Nexus
DossierENTITY

REGN

Coverage of REGN in the Nexus archive.

Earliest in view: Jul 30 · 10:49 UTCMost recent: Jul 30 · 10:49 UTC
Co-mentioned in this coverage
Regeneron Pharmaceuticalsorganization1Tarrytown, New Yorkplace1Automated Insightsorganization1Zacks Investment Researchorganization1
Recent coverage
  • BUSINESSJul 30 · 10:49 UTCWTOP DC
    Regeneron: Q2 Earnings Snapshot

    Regeneron Pharmaceuticals Inc. reported second-quarter profit of $1.3 billion with adjusted earnings of $14.29 per share, surpassing Wall Street's expectation of $10 per share. The company also posted revenue of $4.29 billion, exceeding forecasts of $3.84 billion.

REGN · Dossier · The Nexus